|1||Active, not recruiting||
CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM
|2||Active, not recruiting||
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
† Study has passed its completion date and status has not been verified in more than two years.